Search research articles
Contact Us
Filters
Showing results (131-140 of 725) with videos related to
Page
of 73
Sort By:
Expert Opinion on Medical Diagnostics
|
March 14, 2013
Diagnosis of myalgic encephalomyelitis: where are we now?
Michael Maes, George Anderson, Gerwyn Morris, et al.
Schizophrenia Research
|
March 4, 2019
Paranoid schizophrenia and methamphetamine-induced paranoia are both characterized by a similar LINE-1 partial methylation profile, which is more pronounced in paranoid schizophrenia
Rasmon Kalayasiri, Korakot Kraijak, Apiwat Mutirangura, et al.
Expert Opinion on Therapeutic Targets
|
February 20, 2014
Targeting classical IL-6 signalling or IL-6 trans-signalling in depression?
Michael Maes, George Anderson, Marta Kubera, et al.
Molecular Neurobiology
|
September 27, 2013
The emerging role of autoimmunity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/cfs)
Gerwyn Morris, Michael Berk, Piotr Galecki, et al.
Brain Sciences
|
September 22, 2020
How to Construct a Bottom-Up Nomothetic Network Model and Disclose Novel Nosological Classes by Integrating Risk Resilience and Adverse Outcome Pathways with the Phenome of Schizophrenia
Michael Maes, Aristo Vojdani, Piotr Galecki, et al.
Cellular & Molecular Immunology
|
September 2, 2022
Redox regulation of the immune response
Gerwyn Morris, Maria Gevezova, Victoria Sarafian, et al.
Molecular Neurobiology
|
April 12, 2019
Upregulation of the Intestinal Paracellular Pathway with Breakdown of Tight and Adherens Junctions in Deficit Schizophrenia
Michael Maes, Sunee Sirivichayakul, Buranee Kanchanatawan, et al.
Psychotherapy and Psychosomatics
|
July 27, 2012
Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression
Michael Maes, Frank N M Twisk, Karl Ringel
Frontiers in Psychiatry
|
May 14, 2023
The effects of adverse childhood experiences on depression and suicidal behaviors are partially mediated by neuroticism: A subclinical manifestation of major depression
Ketsupar Jirakran, Asara Vasupanrajit, Chavit Tunvirachaisakul, et al.
Viruses
|
February 28, 2023
Persistent SARS-CoV-2 Infection, EBV, HHV-6 and Other Factors May Contribute to Inflammation and Autoimmunity in Long COVID
Aristo Vojdani, Elroy Vojdani, Evan Saidara, et al.
Page
of 73
Search research articles
Search
Showing results (131-140 of 725) with videos related to
Sort By:
Page
of 73
Expert Opinion on Medical Diagnostics
|
March 14, 2013
Diagnosis of myalgic encephalomyelitis: where are we now?
Michael Maes, George Anderson, Gerwyn Morris, et al.
Schizophrenia Research
|
March 4, 2019
Paranoid schizophrenia and methamphetamine-induced paranoia are both characterized by a similar LINE-1 partial methylation profile, which is more pronounced in paranoid schizophrenia
Rasmon Kalayasiri, Korakot Kraijak, Apiwat Mutirangura, et al.
Expert Opinion on Therapeutic Targets
|
February 20, 2014
Targeting classical IL-6 signalling or IL-6 trans-signalling in depression?
Michael Maes, George Anderson, Marta Kubera, et al.
Molecular Neurobiology
|
September 27, 2013
The emerging role of autoimmunity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/cfs)
Gerwyn Morris, Michael Berk, Piotr Galecki, et al.
Brain Sciences
|
September 22, 2020
How to Construct a Bottom-Up Nomothetic Network Model and Disclose Novel Nosological Classes by Integrating Risk Resilience and Adverse Outcome Pathways with the Phenome of Schizophrenia
Michael Maes, Aristo Vojdani, Piotr Galecki, et al.
Cellular & Molecular Immunology
|
September 2, 2022
Redox regulation of the immune response
Gerwyn Morris, Maria Gevezova, Victoria Sarafian, et al.
Molecular Neurobiology
|
April 12, 2019
Upregulation of the Intestinal Paracellular Pathway with Breakdown of Tight and Adherens Junctions in Deficit Schizophrenia
Michael Maes, Sunee Sirivichayakul, Buranee Kanchanatawan, et al.
Psychotherapy and Psychosomatics
|
July 27, 2012
Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression
Michael Maes, Frank N M Twisk, Karl Ringel
Frontiers in Psychiatry
|
May 14, 2023
The effects of adverse childhood experiences on depression and suicidal behaviors are partially mediated by neuroticism: A subclinical manifestation of major depression
Ketsupar Jirakran, Asara Vasupanrajit, Chavit Tunvirachaisakul, et al.
Viruses
|
February 28, 2023
Persistent SARS-CoV-2 Infection, EBV, HHV-6 and Other Factors May Contribute to Inflammation and Autoimmunity in Long COVID
Aristo Vojdani, Elroy Vojdani, Evan Saidara, et al.
Page
of 73